Medite Cancer Diagnostics, Inc.
MDIT
$0.00
$0.000.00%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
There are no news to display.
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
--
Total Debt (Q)
--
Total Liabilities (Q)
--
Book Value Per Share (Q)
--
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Period Date
Next Filing
(est)
Price History
Beta
7-Day Total Return
--
30-Day Total Return
--
60-Day Total Return
90-Day Total Return
Year to Date Total Return
--
1-Year Total Return
2-Year Total Return
3-Year Total Return
--
5-Year Total Return
52-week Low
52-week High
Dividends and Shares
Shares Outstanding
--
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
407-996-9630
Address
10524 Moss Park Road
Orlando, FL 32832
Orlando, FL 32832
Country
Year Founded
--
Business Description
Sector
Industry
Medite Cancer Diagnostics, Inc. operates as a medical technology company. It develops, manufactures, and markets molecular biomarkers, medical devices, and consumables for the detection, risk...
more
